Today, 36 million people in the European Union (EU) and 30 million in the US with a rare disease face the harsh reality of a ...

The first company to take up residence in Bayer Co.Lab Berlin – initially located on the group's pharma headquarters site in ...

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, ...

A strategy for women's health in England was published in 2022 under the previous Conservative government, led at the time by ...